Table of Contents
ISRN Public Health
Volume 2013 (2013), Article ID 167059, 17 pages
http://dx.doi.org/10.1155/2013/167059
Review Article

Rise of Clinical Trials Industry in India: An Analysis

Centre for Social Medicine and Community Health, Jawaharlal Nehru University, New Delhi 110067, India

Received 10 April 2013; Accepted 19 May 2013

Academic Editors: S. M. Pezzotto, M. San Sebastian, and E. J. Simoes

Copyright © 2013 Vikas Bajpai. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Clinical trials industry has seen a phenomenal increase in last ten years or so, and India has emerged as one of the foremost global destinations for clinical trials. Changed intellectual property regimen after WTO has been the prime mover of the phenomenon, and maximizing profits rather than serving any altruistic motives forms the main ideological underpinning of the rise of clinical trial industry in India. The paper examines the ideological underpinnings of the rise of clinical trials industry in the country in detail and how the ruling classes of India have tried to capitalize on this as a great economic opportunity. In the process the interests of India’s poor have been the main casualty.